Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms
Digestive Diseases and Sciences · 2024
DOI: 10.1007/s10620-024-08369-x ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Magdy El-Salhy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Innovation, Helse Fonna, Tysevegen 64, Stord, 1654, Norway. magdy.elsalhy@sklbb.no. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Irritable Bowel Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Bergen.
Abstract (Originalsprache)
BACKGROUND: Previous studies showed that patients with Severe IBS respond better to fecal microbiota transplantation (FMT) than do those with Moderate IBS. AIMS: The present study aimed to determine the effects of the transplant dose, route of administering it and repeating FMT on this difference. METHODS: This study included 186 patients with IBS randomized 1:1:1 into groups with a 90-g transplant administered once to the colon (LI), once to the duodenum (SI), or twice to the distal duodenum twice (repeated SI). The patients provided a fecal sample and were asked to complete three questionnaires at baseline and at 3, 6, and 12 months after FMT. The fecal bacteria composition and Dysbiosis index were analyzed using 16 S rRNA gene PCR DNA amplification/probe hybridization covering regions V3-V9. RESULTS: There was no difference in the response rates between severe IBS and moderate IBS for SI and repeated SI at all observation intervals after FMT. In the LI group, the response rate at 3 months after FMT was higher for moderate IBS than for severe IBS. The levels of Dorea spp. were higher and those of Streptococcus salivarius subsp. Thermophilus, Alistipes spp., Bacteroides and Prevotella spp., Parabacteroides johnsoni and Parabacteroides spp. were lower in moderate IBS than in severe IBS. CONCLUSIONS: There was no difference in the response to FMT between severe and moderate IBS when a 90-g transplant was administered to the small intestine. The difference in the bacterial profile between severe and moderate IBS may explain the difference in symptoms between these patients. ( www. CLINICALTRIALS: gov : NCT04236843).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research and Innovation, Helse Fonna, Tysevegen 64, Stord, 1654, Norway. magdy.elsalhy@sklbb.no.
- Department of Clinical Medicine, University of Bergen, Bergen, Norway. magdy.elsalhy@sklbb.no.
- National Centre for Functional Gastrointestinal Disorders, Department of Medicine, Haukeland University Hospital, Bergen, Norway. magdy.elsalhy@sklbb.no.
- Department of Clinical Medicine, University of Bergen, Bergen, Norway.
- National Centre for Functional Gastrointestinal Disorders, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Förderung
- University of Bergen
Zitieren
APA
El-Salhy, M., & Hatlebakk, J. G. (2024). Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08369-x
Vancouver
El-Salhy M, Hatlebakk JG. Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08369-x
BibTeX
@article{ElSalhy2024,
author = {El-Salhy, Magdy and Hatlebakk, Jan Gunnar},
title = {Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms},
journal = {Digestive Diseases and Sciences},
year = {2024},
doi = {10.1007/s10620-024-08369-x}
}
EUVIMED